2024. Biosimilar Switching in Rheumatology: Nocebo Effects, Persistence and Communication at Switch. Translational Medicine & Therapeutics Journal. 3, 1 (Apr. 2024), 28–36. DOI:https://doi.org/10.5281/zenodo.22649257.